These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

530 related items for PubMed ID: 21708105

  • 21. Extra-intestinal malignancies in inflammatory bowel disease: results of the 3rd ECCO Pathogenesis Scientific Workshop (III).
    Magro F, Peyrin-Biroulet L, Sokol H, Aldeger X, Costa A, Higgins PD, Joyce JC, Katsanos KH, Lopez A, de Xaxars TM, Toader E, Beaugerie L.
    J Crohns Colitis; 2014 Jan; 8(1):31-44. PubMed ID: 23721759
    [Abstract] [Full Text] [Related]

  • 22. XPD polymorphism and risk of subsequent cancer in individuals with nonmelanoma skin cancer.
    Brewster AM, Alberg AJ, Strickland PT, Hoffman SC, Helzlsouer K.
    Cancer Epidemiol Biomarkers Prev; 2004 Aug; 13(8):1271-5. PubMed ID: 15298945
    [Abstract] [Full Text] [Related]

  • 23. Risk of melanoma and non-melanoma skin cancer in ulcerative colitis patients treated with thiopurines: a nationwide retrospective cohort.
    Abbas AM, Almukhtar RM, Loftus EV, Lichtenstein GR, Khan N.
    Am J Gastroenterol; 2014 Nov; 109(11):1781-93. PubMed ID: 25244964
    [Abstract] [Full Text] [Related]

  • 24. Non-melanoma skin cancer and its risk factors in an Austrian population of heart transplant recipients receiving induction therapy.
    Geusau A, Dunkler D, Messeritsch E, Sandor N, Heidler G, Rödler S, Ankersmit J, Zuckermann A, Tschachler E.
    Int J Dermatol; 2008 Sep; 47(9):918-25. PubMed ID: 18937654
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Immunosuppressive level and other risk factors for basal cell carcinoma and squamous cell carcinoma in heart transplant recipients.
    Fortina AB, Piaserico S, Caforio AL, Abeni D, Alaibac M, Angelini A, Iliceto S, Peserico A.
    Arch Dermatol; 2004 Sep; 140(9):1079-85. PubMed ID: 15381547
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Nonmelanoma Skin Cancer Frequency and Risk Factors in Australian Heart and Lung Transplant Recipients.
    De Rosa N, Paddon VL, Liu Z, Glanville AR, Parsi K.
    JAMA Dermatol; 2019 Jun 01; 155(6):716-719. PubMed ID: 30865218
    [Abstract] [Full Text] [Related]

  • 29. Recent trends in incidence of nonmelanoma skin cancers in the East of Scotland, 1992-2003.
    Brewster DH, Bhatti LA, Inglis JH, Nairn ER, Doherty VR.
    Br J Dermatol; 2007 Jun 01; 156(6):1295-300. PubMed ID: 17535229
    [Abstract] [Full Text] [Related]

  • 30. Thiopurines for inflammatory bowel disease: time to engage with dermatologists?
    Jess T.
    Gastroenterology; 2011 Nov 01; 141(5):1549-51. PubMed ID: 21945060
    [No Abstract] [Full Text] [Related]

  • 31. Melanoma and non-melanoma skin cancer in inflammatory bowel disease patients following tumor necrosis factor-α inhibitor monotherapy and in combination with thiopurines: analysis of the Food and Drug Administration Adverse Event Reporting System.
    McKenna MR, Stobaugh DJ, Deepak P.
    J Gastrointestin Liver Dis; 2014 Sep 01; 23(3):267-71. PubMed ID: 25267954
    [Abstract] [Full Text] [Related]

  • 32. Trends of nonmelanoma skin cancer from 1960 through 2000 in a Canadian population.
    Demers AA, Nugent Z, Mihalcioiu C, Wiseman MC, Kliewer EV.
    J Am Acad Dermatol; 2005 Aug 01; 53(2):320-8. PubMed ID: 16021129
    [Abstract] [Full Text] [Related]

  • 33. Markedly reduced incidence of melanoma and nonmelanoma skin cancer in a nonconcurrent cohort of 10,040 patients with vitiligo.
    Paradisi A, Tabolli S, Didona B, Sobrino L, Russo N, Abeni D.
    J Am Acad Dermatol; 2014 Dec 01; 71(6):1110-6. PubMed ID: 25242557
    [Abstract] [Full Text] [Related]

  • 34. Occurrence of other cancers among patients with prior basal cell and squamous cell skin cancer.
    Karagas MR, Greenberg ER, Mott LA, Baron JA, Ernster VL.
    Cancer Epidemiol Biomarkers Prev; 1998 Feb 01; 7(2):157-61. PubMed ID: 9488591
    [Abstract] [Full Text] [Related]

  • 35. Nonmelanoma skin cancer after renal transplantation: a single-center experience in 1736 transplantations.
    Zavos G, Karidis NP, Tsourouflis G, Bokos J, Diles K, Sotirchos G, Theodoropoulou E, Kostakis A.
    Int J Dermatol; 2011 Dec 01; 50(12):1496-500. PubMed ID: 21790552
    [Abstract] [Full Text] [Related]

  • 36. Nonmelanoma skin cancer in an Irish population: an appraisal of risk factors.
    Healy E, Collins P, Barnes L.
    Ir Med J; 1995 Dec 01; 88(2):58-9. PubMed ID: 7775148
    [Abstract] [Full Text] [Related]

  • 37. Nonmelanoma skin carcinoma in Albuquerque, New Mexico: experience of a major health care provider.
    Hoy WE.
    Cancer; 1996 Jun 15; 77(12):2489-95. PubMed ID: 8640697
    [Abstract] [Full Text] [Related]

  • 38. Incidence and clinical predictors of a subsequent nonmelanoma skin cancer in solid organ transplant recipients with a first nonmelanoma skin cancer: a multicenter cohort study.
    Tessari G, Naldi L, Boschiero L, Nacchia F, Fior F, Forni A, Rugiu C, Faggian G, Sassi F, Gotti E, Fiocchi R, Talamini G, Girolomoni G.
    Arch Dermatol; 2010 Mar 15; 146(3):294-9. PubMed ID: 20231501
    [Abstract] [Full Text] [Related]

  • 39. Risks of Melanoma and Nonmelanoma Skin Cancers Pre- and Post-Inflammatory Bowel Disease Diagnosis.
    Narous M, Nugent Z, Singh H, Bernstein CN.
    Inflamm Bowel Dis; 2023 Jul 05; 29(7):1047-1056. PubMed ID: 35929649
    [Abstract] [Full Text] [Related]

  • 40. Mortality Associated With Development of Squamous Cell Cancer in Patients With Inflammatory Bowel Diseases Receiving Treatment With Thiopurines.
    Khan N, Lee H, Trivedi C, Kavani H, Medvedeva E, Xie D, Lewis JD, Yang YX.
    Clin Gastroenterol Hepatol; 2019 Oct 05; 17(11):2262-2268. PubMed ID: 30853615
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 27.